180 related articles for article (PubMed ID: 38555997)
1. Antibody Conjugated Nano-Enabled Drug Delivery Systems Against Brain Tumors.
Topçu BT; Bozdağ Pehlivan S; Akdağ Y; Mut M; Öner L
J Pharm Sci; 2024 Jun; 113(6):1455-1469. PubMed ID: 38555997
[TBL] [Abstract][Full Text] [Related]
2. Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes.
Gu J; Al-Bayati K; Ho EA
Drug Deliv Transl Res; 2017 Aug; 7(4):497-506. PubMed ID: 28315051
[TBL] [Abstract][Full Text] [Related]
3. ANG4043, a novel brain-penetrant peptide-mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice.
Regina A; Demeule M; Tripathy S; Lord-Dufour S; Currie JC; Iddir M; Annabi B; Castaigne JP; Lachowicz JE
Mol Cancer Ther; 2015 Jan; 14(1):129-40. PubMed ID: 25492620
[TBL] [Abstract][Full Text] [Related]
4. Glioma Dual-Targeting Nanohybrid Protein Toxin Constructed by Intein-Mediated Site-Specific Ligation for Multistage Booster Delivery.
Chen Y; Zhang M; Jin H; Li D; Xu F; Wu A; Wang J; Huang Y
Theranostics; 2017; 7(14):3489-3503. PubMed ID: 28912890
[TBL] [Abstract][Full Text] [Related]
5. Blood-Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles.
Thomsen MS; Johnsen KB; Kucharz K; Lauritzen M; Moos T
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297671
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles Containing a Combination of a Drug and an Antibody for the Treatment of Breast Cancer Brain Metastases.
Wyatt EA; Davis ME
Mol Pharm; 2020 Feb; 17(2):717-721. PubMed ID: 31916770
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive nanoparticle strategies for brain tumor targeting.
Sun C; Ding Y; Zhou L; Shi D; Sun L; Webster TJ; Shen Y
Nanomedicine; 2017 Nov; 13(8):2605-2621. PubMed ID: 28756093
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors.
Reddy S; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 Aug; 26(8):1944-1952. PubMed ID: 33865978
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends.
Choudhury H; Pandey M; Chin PX; Phang YL; Cheah JY; Ooi SC; Mak KK; Pichika MR; Kesharwani P; Hussain Z; Gorain B
Drug Deliv Transl Res; 2018 Oct; 8(5):1545-1563. PubMed ID: 29916012
[TBL] [Abstract][Full Text] [Related]
11. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
[TBL] [Abstract][Full Text] [Related]
12. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
13. Exploring Therapeutic Advancement and Strategies Associated with Drug Delivery in Brain-Tumor Targeting.
Stephen BJ; Sharma MM; Jain D; Dhaliwal H; Sharma V; Singh A
Crit Rev Ther Drug Carrier Syst; 2021; 38(2):1-25. PubMed ID: 33639066
[TBL] [Abstract][Full Text] [Related]
14. Micro-Nanocarriers Based Drug Delivery Technology for Blood-Brain Barrier Crossing and Brain Tumor Targeting Therapy.
Wang L; Shi Y; Jiang J; Li C; Zhang H; Zhang X; Jiang T; Wang L; Wang Y; Feng L
Small; 2022 Nov; 18(45):e2203678. PubMed ID: 36103614
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
Gao H
J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
[TBL] [Abstract][Full Text] [Related]
16. The significance of transferrin receptors in oncology: the development of functional nano-based drug delivery systems.
Tortorella S; Karagiannis TC
Curr Drug Deliv; 2014; 11(4):427-43. PubMed ID: 24387131
[TBL] [Abstract][Full Text] [Related]
17. Biogenic gold nanoparticles: As a potential candidate for brain tumor directed drug delivery.
Tripathi RM; Shrivastav A; Shrivastav BR
Artif Cells Nanomed Biotechnol; 2015; 43(5):311-7. PubMed ID: 24588231
[TBL] [Abstract][Full Text] [Related]
18. In vivo Glioblastoma Therapy Using Targeted Liposomal Cisplatin.
Ashrafzadeh MS; Akbarzadeh A; Heydarinasab A; Ardjmand M
Int J Nanomedicine; 2020; 15():7035-7049. PubMed ID: 33061366
[TBL] [Abstract][Full Text] [Related]
19. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
20. Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.
Han L; Kong DK; Zheng MQ; Murikinati S; Ma C; Yuan P; Li L; Tian D; Cai Q; Ye C; Holden D; Park JH; Gao X; Thomas JL; Grutzendler J; Carson RE; Huang Y; Piepmeier JM; Zhou J
ACS Nano; 2016 Apr; 10(4):4209-18. PubMed ID: 26967254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
